– Reuters Citing AP
Morgan Stanley Maintains Overweight on Microsoft, Lowers Price Target to $325
Morgan Stanley analyst Keith Weiss maintains Microsoft (NASDAQ:MSFT) with a Overweight and lowers the price target from $354 to $325.
Related Posts
LianBio Announces China National Medical Products Administration Acceptance With Priority Review Of New Drug Application For Mavacamten For The Treatment Of Patients With Obstructive Hypertrophic Cardiomyopathy
LianBio (NASDAQ:LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that China's National Medical Products Administration
Needham Maintains Buy on CryoPort, Raises Price Target to $42
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $41 to $42.
Johnson & Johnson Q2 Adj. EPS $2.59 Beats $2.57 Estimate, Sales $24.02B Beat $23.81B Estimate
Johnson & Johnson (NYSE:JNJ) reported quarterly earnings of $2.59 per share which beat the analyst consensus estimate of $2.57 by 0.78 percent. This is a 4.44 percent increase over earnings of $2.48 per share from the